Philip B. Donenberg is Sr. VP of Finance & CFO & Secy at BIOSANTE PHARMACEUTICALS INC (BPAX). They have made 7 open-market trades across 2 companies since 2006, most recently 2011-08-08.
CIK 0001238120
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $17K since 2006, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BPAX | BUY | 2011-08-08 | 2011-08-09 | $2.23 | $2K | N/A | N/A | N/A |
| BPAX | BUY | 2011-08-05 | 2011-08-08 | $2.19 | $2K | N/A | N/A | N/A |
| BPAX | BUY | 2011-01-21 | 2011-01-21 | $1.88 | $2K | N/A | N/A | N/A |
| BPAX | BUY | 2011-01-19 | 2011-01-20 | $1.88 | $2K | N/A | N/A | N/A |
| BPAX | BUY | 2008-12-31 | 2009-01-05 | $1.00 | $3K | N/A | N/A | N/A |
| BPAX | BUY | 2007-12-14 | 2007-12-17 | $3.76 | $4K | N/A | N/A | N/A |
| BPA | BUY | 2006-07-20 | 2006-07-20 | $1.95 | $2K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.